Allergy & Immunology Doctors in Rancho Cucamonga, CA Accepting Medicare

2 Allergy & Immunology doctors found. Showing 1 - 2

Henry Lin, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 8008 Monet Ave, Suite 107, Rancho Cucamonga, CA 91739 Phone: 909-463-6900    Fax: 909-463-1430

Joshua G Gibbs, D.O. Allergy & Immunology - Clinical & Laboratory Immunology Medicare: Accepting Medicare Assignments Practice Location: 9045 Haven Ave Ste 101, Rancho Cucamonga, CA 91730 Phone: 909-944-9058

News Archive

Outbreak of whooping cough mirrors challenges in developing world, global health official says

The outbreak of whooping cough in Texas, California, and other states this year underscores the critical importance of widespread vaccination coverage, both locally as well as around the world, said a leading global health official attending conferences on world affairs and immunization in Fort Worth this week.

A promising vaccine for treating poorly immunogenic tumors

Patients with cancer have multiple treatment options available to them today, but each has its drawbacks. Chemotherapy kills rapidly dividing cancer cells, but it also damages healthy cells in the body and often does not effectively prevent tumor metastasis or disease recurrence.

Pulmatrix completes previously announced merger and closes $10 million in private placement

Pulmatrix, Inc., previously known as Ruthigen, Inc., today announced the completion of its previously announced merger, effective June 15, 2015, and the closing of a private placement generating aggregate gross proceeds of $10.0 million. Participants in the private placement included pre-merger investors in Pulmatrix such as funds affiliated with 5AM Ventures, ARCH Venture Partners and Polaris Partners, as well as funds affiliated with Altitude Life Science Ventures.

GSK, Genmab to refocus on ofatumumab development program in autoimmune indications

GlaxoSmithKline and Genmab A/S Following the 1st July announcement by GSK and Genmab of an amendment to the collaborative agreement for ofatumumab in which GSK assumed development responsibility for autoimmune indications, GSK and Genmab announced today plans to refocus the development program of ofatumumab in autoimmune indications.

Read more Medical News

› Verified 1 days ago